About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Trial of JYB1904 in Patients With Allergic Asthma | Clinical Trials | Clareo Health

Back to clinical trial search

Active Not RecruitingPhase 2NCT06438757

Trial of JYB1904 in Patients With Allergic Asthma

This phase IIa trial is meant to evaluate the pharmacokinetics, pharmacodynamics and safety of JYB1904 in patients with allergic asthma.

Lead sponsor: Jemincare•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

Jemincare

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Able to provide written informed consent voluntarily;
•Aged 18-75 years, weight ≥ 40 kg, male or female;
•Diagnosed Allergic asthma.

Exclusion Criteria

•Prior exposure to anti-IgE therapy within 1 year;
•Allergic to anti-IgE biologics;
•Current smokers, or quit smoking within 1 year;
•Combined with other non-allergic diseases that cause IgE elevation；
•History of malignancy, autoimmune diseases, Immune complex mediated diseases, Hypereosinophilic syndrome;
•Other conditions unsuitable for the trial judged by the investigator.

Related studies

RECRUITINGPhase 2

Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma

NCT05008965 · Allergic Asthma

RECRUITINGPhase 3

A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma (HAS3)

NCT04699604 · Allergic Asthma

Enrolling By InvitationEARLY Phase 1

Asthma Inflammation Research

NCT01536522 · Asthma, Allergic Asthma, and more

Enrolling By Invitation

Evaluate Measurement Instruments Relevance in Assessing Effectiveness of ACARIZAX® in House Dust Mite Allergic Rhinitis

NCT06151938 · Allergic Rhinitis Due to House Dust Mite, Allergic Asthma

Active Not Recruiting

Tyrosine Allergoid Paediatric and Adult Study

NCT05186025 · Allergic Rhinitis Due to Pollen, Allergic Conjunctivitis, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 7, 2025Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

PhasePHASE2

Enrollment69

Start dateJun 2024

Last updatedMay 7, 2025

Condition

Allergic Asthma

Locations shown

Shanghai General Hospital

Shanghai, Shanghai Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 7, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions